Zhongyi (Pierce) WU is an experienced leader in the pharmaceutical industry, currently serving as AVP and Head of New Assets at AstraZeneca since 2025. Previously, they held multiple strategic roles at Takeda, including Market Access Lead for Europe and Canada, where they optimized operating models and successfully launched products in rare diseases. WU's earlier experience includes significant contributions at companies like Sanofi, Nielsen, and Ipsos, focusing on market strategy and project management. They are dedicated to bringing innovations to patients through their comprehensive expertise in commercialization and market access.
This person is not in the org chart
This person is not in any teams
This person is not in any offices